Future studies examining the function of the DNMT3A R882 mutation in vitro and in vivo in the presence of wildtype DNMT3A will hopefully shed further light on a pathogenic mechanism of DNMT3a mutations in AML. Here, DNMT3A is linked to acute myeloid leukemia.